November 14, 2017 Comments (0) Views: 2047 Biotech, Biotech Briefing, Blog

Biotech Briefing: Heron Therapeutics’ Cinvanti Receives FDA Approval

Plus: Tear Film completes $9 million Series A financing and Senomyx expands “Cool Program”

Reports + Research

Heron Therapeutics Receives FDA approval for Cinvanti

Cinvanti was approved for the prevention of acute and delayed nausea and vomiting associated with certain chemotherapy treatments. Heron now is the only franchise that has two approved drugs that address both mechanisms of chemotherapy-induced nausea and vomiting.

Odonate Files for a $173 Million IPO

According to Renaissance Capital, San Diego’s Odonate Therapeutics filed on Monday with the SEC to raise up to $173 million in an initial public offering. The company is developing tesetaxel, a novel orally-administered taxane, and they are initiating multinational, multicenter, Phase 3 study in locally advanced or metastatic breast cancer.

Tear Film Completes $9 Million Series A Financing

Tear Film Innovations will use the proceeds of the financing to advance the company’s evaporative dry eye treatment system through regulatory approvals to commercialization. Tear Film’s lead product candidate is called the iLux Device and is designed to identify and unblock meibomian glands. Visionary Ventures and Tigris Ventures led the financing.

Senomyx Expands “Cool Program” with Firmenich

Senomyx and Firmenich expanded their Cool Program collaboration, getting $10 million upfront payment for Senomyx for an exclusive license and pre-payment of certain royalty obligations. The exclusive license includes Coolmyx CL19 and related cooling ingredients in all product categories.

Read + Listen

POW! Podcast of the Week

For Diabetes Awareness Month, I suggest a podcast from American Diabetes Associated called Diabetes Core Updates. Each episode is approximately 20 minutes long and presents five to six recently-published, articles from the ADA’s four scholarly journals: Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum.

BOW! Book of the Week

Did you know one in three people in the United States will develop type 2 diabetes in their lifetime? Here’s a book about dealing with disease: Cheating Destiny.

Events

It’s Happening Here

November 15
On November 15 take a first look at the 2018 California Life Sciences Industry Report.

November 16
Biocom Annual “Celebration of Life” Dinner will take place November 16. The James Bond-inspired event, “Dare to be Extraordinary,” will feature Scott Hamilton and Karolyn Smith as the dinner speakers.